The antibiotic resistance project

Drug resistance is causing increasing problems for the global population. By 2050, the WHO estimates that the number of deaths caused by antibiotic resistance will be the same as for cancer. Additionally, the resulting healthcare costs will be staggering. Besides developing new antibiotics, it is crucial to advance realistic alternatives and to make sure that existing antibiotics stay effective. Surveys verify that homeopathy, for instance, is effective in infections of the upper airways. By using homeopathic remedies, prescribing antibiotics can be significantly reduced. 

Furthermore, best practice has shown that infections with resistant pathogens can be successfully treated by applying CAM processes. This is why we are trying to gain further insight into such processes and use them sensibly for patient welfare and safety.


What is our approach to antibiotic resistance?

This project is still at an early stage. Compared to cancer therapies, there is very little clinical data available. Therefore, in a first step, we will analyse the current research results and then capture the clinical data gained. The question is whether infections with resistant pathogens can be treated with homeopathic substances. The next question will be:  How can the application of antibiotics in trivial diseases be sensibly reduced in order to avoid drug resistances? At a further project stage, we will also run in-vitro tests to benefit from the entire range of available homeopathic remedies.